Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

1020

Full text

868

Free full text

419

Publication Types

Journal Article

1032

Research Support, Non-U.S. Gov't

393

Review

384

Randomized Controlled Trial

237

Multicenter Study

159

Comparative Study

157

Observational Study

Clinical Trial

Meta-Analysis

Systematic Review

Research Support, N.I.H., Extramural

Clinical Trial, Phase II

Clinical Trial, Phase I

Clinical Trial, Phase III

Network Meta-Analysis

Case Reports

Letter

Controlled Clinical Trial

Research Support, U.S. Gov't, P.H.S.

Research Support, U.S. Gov't, Non-P.H.S.

Comment

Editorial

Research Support, N.I.H., Intramural

Clinical Trial Protocol

Consensus Development Conference

Practice Guideline

Clinical Trial, Phase IV

Evaluation Study

Equivalence Trial

Validation Study

Retracted Publication

Historical Article

Video-Audio Media

Scoping Review

News

Pragmatic Clinical Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Pyrazoles""[mesh_terms]

1057 Results

Searching titles within these results

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial.

Robert J Pignolo, Geneviève Baujat, Edward C Hsiao, Richard Keen, Amy Wilson, Jeff Packman, Andrew L Strahs, Donna R Grogan, Frederick S Kaplan

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2022;37(10):1891-1902

Free Full Text

Abstract

Novel Niacin Receptor Agonists: A Promising Strategy for the Treatment of Dyslipidemia.

Prajakta B Kothawade, Asha B Thomas, Sohan S Chitlange

Mini reviews in medicinal chemistry 2021;21(17):2481-2496

Full Text

Abstract

Synthesis of Fluorescent Pyrazoline Sensors as Versatile Tool for Zinc ion Detection: A Mini-Review.

Suhail Ahmad, Salman A Khan, Md Zafer Alam

Journal of fluorescence 2025;35(3):1241-1253

Full Text

Abstract

Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve.

Tracy Y Wang, Lars G Svensson, Jun Wen, Andrew Vekstein, Marc Gerdisch, Vijay U Rao, Michael Moront, Doug Johnston, Renato D Lopes, Alma Chavez, Marc Ruel, Eugene H Blackstone, Richard C Becker, Vinod Thourani, John Puskas, Hussein R Al-Khalidi, David G Cable, John A Elefteriades, Alberto Pochettino, J Alan Wolfe, Allen Graeve, Ibrahim Sultan, Ashraf A Sabe, Hector I Michelena, John H Alexander

NEJM evidence 2024;2(7):EVIDoa2300067

Full Text

Abstract

A Pharmacokinetic, Safety, and Tolerability Trial of Palovarotene in Healthy Japanese and Non-Japanese Participants.

Louise Dube, Nobuhiko Haga, Donna Grogan, Julien Ogier, Kim-Hanh Le Quan Sang

European journal of drug metabolism and pharmacokinetics 2023;48(2):141-150

Free Full Text

Abstract

Modeling covalent-modifier drugs.

Ernest Awoonor-Williams, Andrew G Walsh, Christopher N Rowley

Biochimica et biophysica acta. Proteins and proteomics 2018;1865(11 Pt B):1664-1675

Full Text

Abstract

Hydrolysis of mefenpyrdiethyl: an analytical and DFT investigation.

Amina Chnirheb, Mourad Harir, Basem Kanawati, Agnes Fekete, Mohammed El Azzouzi, Norbert Hertkorn, Philippe Schmitt-Kopplin

Analytical and bioanalytical chemistry 2011;398(5):2325-34

Full Text

Abstract

Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches.

Vivek Asati, Arjun Anant, Preeti Patel, Kamalpreet Kaur, G D Gupta

European journal of medicinal chemistry 2022;225():113781

Full Text

Abstract

Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY.

Alexander T Cohen, Sharon Pan, Wonkyung Byon, Bushra S Ilyas, Thomas Taylor, Theodore C Lee

Advances in therapy 2021;38(6):3003-3018

Free Full Text

Abstract

Hypersensitivity reactions to non-vitamin K oral anticoagulants - a review of literature and diagnostic work-up proposal.

G Carli, A Farsi, F Chiarini, D Lippolis, G Cortellini

European annals of allergy and clinical immunology 2020;51(1):7-14

Free Full Text

Abstract

Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis.

Ronpichai Chokesuwattanaskul, Charat Thongprayoon, Tanyanan Tanawuttiwat, Wisit Kaewput, Pavida Pachariyanon, Wisit Cheungpasitporn

Pacing and clinical electrophysiology : PACE 2019;41(6):627-634

Full Text

Abstract

Antidotes for poisoning by alcohols that form toxic metabolites.

Kenneth McMartin, Dag Jacobsen, Knut Erik Hovda

British journal of clinical pharmacology 2016;81(3):505-15

Free Full Text

Abstract

New frontiers in anticoagulation: non vitamin-K oral anticoagulants in stroke prevention.

Valentina Arnao, Marianna Riolo, Antonino Tuttolomondo, Antonio Pinto, Brigida Fierro, Paolo Aridon

Expert review of neurotherapeutics 2017;17(6):539-552

Full Text

Abstract

Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trial.

Karim Fizazi, Neal D Shore, Matthew Smith, Rodrigo Ramos, Robert Jones, Günter Niegisch, Egils Vjaters, Yuan Wang, Shankar Srinivasan, Toni Sarapohja, Frank Verholen

European journal of cancer (Oxford, England : 1990) 2023;192():113258

Free Full Text

Abstract

Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study.

Aung Naing, John D Powderly, John J Nemunaitis, Jason J Luke, Aaron S Mansfield, Wells A Messersmith, Solmaz Sahebjam, Patricia M LoRusso, Ignacio Garrido-Laguna, Lance Leopold, Ryan Geschwindt, Kai Ding, Michael Smith, Jordan D Berlin

Journal for immunotherapy of cancer 2022;10(3):e004223

Free Full Text

Abstract

Results: 1 – 15 / 1057

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Pyrazoles""[mesh_terms]

Palovarotene for Fibrodysplasia Ossificans Progressiva (FOP): Results of a Randomized, Placebo-Controlled, Double-Blind Phase 2 Trial.

Novel Niacin Receptor Agonists: A Promising Strategy for the Treatment of Dyslipidemia.

Synthesis of Fluorescent Pyrazoline Sensors as Versatile Tool for Zinc ion Detection: A Mini-Review.

Apixaban or Warfarin in Patients with an On-X Mechanical Aortic Valve.

A Pharmacokinetic, Safety, and Tolerability Trial of Palovarotene in Healthy Japanese and Non-Japanese Participants.

Modeling covalent-modifier drugs.

Hydrolysis of mefenpyrdiethyl: an analytical and DFT investigation.

Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches.

Efficacy, Safety, and Exposure of Apixaban in Patients with High Body Weight or Obesity and Venous Thromboembolism: Insights from AMPLIFY.

Hypersensitivity reactions to non-vitamin K oral anticoagulants - a review of literature and diagnostic work-up proposal.

Safety and efficacy of apixaban versus warfarin in patients with end-stage renal disease: Meta-analysis.

Antidotes for poisoning by alcohols that form toxic metabolites.

New frontiers in anticoagulation: non vitamin-K oral anticoagulants in stroke prevention.

Efficacy and safety outcomes of darolutamide in patients with non-metastatic castration-resistant prostate cancer with comorbidities and concomitant medications from the randomised phase 3 ARAMIS trial.

Exploring the safety, effect on the tumor microenvironment, and efficacy of itacitinib in combination with epacadostat or parsaclisib in advanced solid tumors: a phase I study.

Results for
""Pyrazoles""[mesh_terms]